Skip to main content
. 2015 Oct 25;7(1):418–432. doi: 10.18632/oncotarget.6225

Table 3. Uni- and multivariate analyses of rpS6 and p-rpS6 expression and clinical/pathologic features for the prediction of cancer specific survival in patients with RCCs.

Univariate Analysis Multivariate Analysis
Hazard Ratio (95 % CI) p Hazard Ratio (95 % CI) p
rpS6 & p-rpS6 1.7 (1.3-2.3) <0.001 1.9 (1.4-2.6) <0.001
Karnofsky* 2.6 (1.9-3.4) <0.001 1.6 (1.2-2.2) 0.002
Tumor extent 5.7 (4.2-7.8) <0.001 2.9 (2-4.2) <0.001
Regional lymph node metastasis 7.1 (4.9-10.1) <0.001 1.6 (1.1-2.4) 0.03
Distant metastasis± 10.6 (7.7-14.4) <0.001 5.1 (3.5-7.3) <0.001
Grade of malignancy 5.4 (3.9-7.3) <0.001 1.8 (1.3-2.5) 0.001
Type of surgeryt 4.5 (2.1-9.7) <0.001 1.9 (0.9-4.3) 0.10
Sex = 1.6 (1.2-2.2) 0.003 1.3 (0.9-1.8) 0.15
Histopathologic subtype< 1.6 (1.2-2.2) 0.003 1.2 (0.7-1.9) 0.5
p-rpS6 Expression 1.9 (1.4-2.6) <0.001 1.4 (1-1.9) 0.03
Karnofsky* 2.3 (1.8-3) <0.001 1.7 (1.3-2.2) <0.001
Tumor extent 5.6 (4.2-7.5) <0.001 2.8 (2-3.8) <0.001
Regional lymph node metastasis 6.8 (4.9-9.5) <0.001 1.7 (1.2-2.5) 0.006
Distant metastasis± 10.8 (8.1-14.4) <0.001 5 (3.6-7) <0.001
Grade of malignancy 5.3 (4-7) <0.001 1.9 (1.4-2.6) <0.001
Type of surgeryt 3.4 (1.9-6) <0.001 1.2 (0.7-2.3) 0.51
Sex = 1.6 (1.2-2.2) 0.001 1.4 (1-1.9) 0.04
Histopathologic subtype< 1.6 (1.2-2.2) 0.001 1.1 (0.7-1.8) 0.56
rpS6 Expression 1.8 (1.4-2.4) <0.001 1.8 (1.4-2.4) <0.001
Karnofsky* 2.5 (1.9-3.2) <0.001 1.7 (1.3-2.3) <0.001
Tumor extent 5.9 (4.3-7.9) <0.001 2.8 (2-3.9) <0.001
Regional lymph node metastasis 5.9 (4.2-8.3) <0.001 1.4 (0.9-2) 0.13
Distant metastasis± 10.3 (7.7-13.8) <0.001 4.9 (3.5-6.8) <0.001
Grade of malignancy 5.8 (4.3-7.7) <0.001 1.9 (1.4-2.6) <0.001
Type of surgeryt 5 (2.4-10.1) <0.001 1.9 (0.9-3.9) 0.1
Sex = 1.6 (1.2-2.2) 0.001 1.5 (1.1-2) 0.015
Histopathologic subtype< 1.6 (1.2-2.2) 0.001 1.1 (0.7-1.8) 0.6

Immunistochemical intensity low vs. high

*

<80% vs >= 80%

pT3/pT4 vs pT1/pT2

pN1/pN2 vs pN0/N0

±

M0 vs M1

G1/G2 vs G3/G4

=

Male vs female

t

Radical vs partial nephrectomy

<

Clear-cell (conventional) vs other types